Treatt is a world-leading manufacturer and supplier of flavour, fragrance and cosmetic ingredients. Our diverse product portfolio is the result of over 125 years of technical expertise and experience in the global sourcing of flavour and fragrance raw materials. Through our cosmetics division, Earthoil, we also offer naturally-derived cosmetic ingredients, specialising in organic and fair trade, reflecting our commitment to ethical and sustainable practices.

http://www.treatt.com/

Treatt: Investec takes target price from 470p to 610p retaining a buy recommendation.

Treatt soars after update
Tue 28 May 2013


Treatt soars after update LONDON (SHARECAST) - Shares of Treatt, an ingredients supplier to the flavour and fragrance industries, soared after it said it expects to exceed company expectations for the current financial year.

The group's shares spiked earlier this month after it revealed a 30% hike in pre-tax profits and a 40% surge in earnings per share. In today's update it said momentum has continued.

Treatt said sales for May 2013 are expected to reach an all-time high and order books for the remainder of the third and fourth quarter now look promising.

"The positive commercial environment, coupled with the continuing impact of the board's new strategy, and the lower overheads and improved margins it is delivering, means that the board expects to exceed its expectations for the current financial year," it said in a company statement.

"Looking further ahead, the strategic creation of a global sales structure, which is clearly focused on selling value-added ingredient solutions with its emphasis on multi-national consumer goods companies, is already leading to significant new opportunities for growth," it added.

Treatt said it would focus on developing new products for the beverage sector where the possibilities for growing sales are 'material'.

It added that momentum now in the business and the benefits from significant cost saving measures will extend beyond the current financial year and that the prospects for the business for the years ending September 30th 2014 and 2015 are also improved.

Its shares jumped 13.33% or 65.00p to 552.50p at 12:30 in London.

Well done here!

Thanks skinny, needs to slowdown.

Investment summary: Appealing flavours

http://www.edisoninvestmentresearch.com/researchreports/Treatt280513QV.pdf

On fundamentals, still not expensive imo. This is a niche little business, historically run as almost as a private company (Bovill family) which just happened to have a listing. New CEO appears more commercially orientated. Improved margins, lower overheads mean that for a manufacturer like this I would think that if they should be capable of at least 10% of revenues in pre tax profit - and possibly more. Sales currently also rising, so not out of the question they will reach £100M in next few years, which would give eps perhaps 65p. Asking quite a lot, maybe, but after holding quite a few years I am not selling mine any time soon. Cash was an issue in the first half and will be scutinised when full year figures come out later in the year. Just hope an opportunistic predator does not come along too soon - Bovill family has said their stake (around 29% in all) is up for sale, but thier expectations must have risen after the last few weeks. Always dyor.

Thanks for the update partridge, very interesting.

Treatt PLC (TET:LSE) set a new 52-week high during today's trading session when it reached 588.00. Over this period, the share price is up 72.82%.Share price forecast




The one analyst offering a 12 month price target expects Treatt plc share price to rise to 610.00 in the next year from the last price of 566.00.

:-))

Covered in this weeks IC- A real Treatt

We didn't have long to wait for shares in Treatt, a world-leading manufacturer and supplier of flavour, fragrance and cosmetic ingredients, to re-rate. IN fact, following two weeks since an upbeat trading statement on 28 May, shares in the company have soared to a record high and have produced a bumper 24% return in the two weeks since IC highlighted the investment. As a result, analyst Nicola Mallard at investec securities has massively upgraded her pre-tax profit estimate for the 12 months to end September from £5m to £6m. On this basis, previous EPS forecasts of 34.7p are lifted to 41.9p. IC has a new fair value target price of 600p, to potentially offer a further 10% upside.

Well done on your short term profit dc. Interesting how strategies differ. I belong to the "buy and hold" school of Buffett, which has stood me in very good stead on the likes of Halma, AG Barr and PZ Cussons. Had an interest in Treatt for over 10 years, collecting decent divis and patiently waiting for it to take off. It is still early days of the new broom CEO, but I bought these for my two sons ISAs last year and told them not to sell for at least ten years! IC target is in my view short term - long term might be a lot better, if they stay independent, but always dyor.

Thank you p. I think the investor who purchased these late 2008 must be very happy now.(Below 180p with a constant climb to the present sp). You have to stick to the strategy that suits you. If only we had a crystal ball.
Very nice to be investing for your sons future and I am sure this company will indeed do very well in the future. I will add any news to the thread to keep investors up to date. Thank you p for your knowledge in this company.

Illiquid, but only buy so far today gone through at 600p. dc - IC target may be reached sooner than they expected! Quite heavily invested here by my standards, so will wait for IMS next month before considering more. Comment recently about the use of the stevia plant as a natural sweetener to replace sugar in beverages and from their website artices some interesting products from Treatt to go alongside. Warm feeling about this remains, but always dyor.

Still rising, despite general doom amd gloom on the market. Hopeful that IMS due next month will show the business capable of eps 40p in year to Sept 2013 - and better to come. If that proves to be the case, still not expensive imo, but always dyor.

Treatt: Investec downgrades from buy to hold with a target price of 610p.

Bovill Family Concert Party Placing

http://www.moneyam.com/action/news/showArticle?id=4630088

Sale of Interest in Treatt plc

RNS


RNS Number : 0450J

The Bovill Family

10 July 2013





10 July 2013

Sale of Interest in Treatt plc

As announced on 19 March 2013, the Bovill Family has been exploring ways in which to realise the intrinsic value of their shareholding in Treatt plc ("Treatt" or the "Company"). The Bovill Family announces today that, with assistance from its financial adviser Grant Thornton UK LLP and in collaboration with the Company and its financial adviser Investec Bank plc, the Bovill Family has successfully disposed of 2,950,992 Treatt shares at a price of £5.20 per Treatt share.

As also announced on 19 March 2013, the Bovill Family has been co-operating with Bjornstad and Jendal A/S in relation to the sale of their collective interests in Treatt shares. The Bovill Family are aware that Bjornstad and Jendal A/S has also disposed of its entire shareholding in Treatt today.

The Bovill Family believe that their stewardship of the business has built a strong foundation for Treatt and positioned it well for the next stage of its development.

Thanks dc. Personally, I am pleased that this stake has nor been acquired as prelude to opportunistic bid and see drop in price as buying opportunity, but always dyor.

Director Deals - Treatt PLC (TET)

BFN

Richard Hope, Financial Director, bought 10,552 shares in the company on the 11th July 2013 at a price of 575.00p. The Director now holds 26,372 shares.

Story provided by StockMarketWire.com
Director deals data provided by www.directorsholdings.com